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Introduction
Patent foramen ovale (PFO) is a slit or tunnel like passage 
in the interatrial septum formed by failure of postnatal fusion 
of the septum primum and septum secundum. Persistent 
PFO occurs in around 20-25% of the adult population.1) PFO 
has been known to be the cause of transient ischemic attacks 
(TIA) or stroke. Meta-analyses and observational studies indi-
cate that the prevalence of PFO is approximately 3-fold higher 
in patients with cryptogenic stroke and migraine compared to 
controls. Conversely, observational evidences indicate a 2-3-
fold increased prevalence of migraine and cerebrovascular 
events in PFO carriers.2) Transcatheter device closure has been 
the treatment of choice for these defects.
The persistent left superior vena cava (LSVC) is the most 
common abnormality of systemic venous return. It has been 
observed in 0.5% of the general population and in up to 10% 
of patients with congenital heart disease.3)4) This anomaly is 
due to an abnormal development of the sinus venosus in the 
early stages of fetal life. In 92% of cases, drainage occurs in the 
right atrium; in the remainder of cases, drainage occurs in the 
left atrium (LA), either directly or through an unroofed coro-
nary sinus.5) Combined defect of abnormal drainage of LSVC 
to left superior pulmonary vein (LSPV) in PFO patients is un-
common, and we report simultaneous device closure of LSVC 
with Amplatzer® Vascular Plug II (St. Jude Medical, St. Paul, 
MN, USA). 
Case 
A 37-year-old female patient with chief complaint of left 
arm weakness (duration less than 1 minute) and left-sided lip 
twitching was diagnosed with PFO under evaluation at 
Myongji Hospital. Laboratory test results showed normal val-
ue of erythrocyte sedimentation rate, C-reactive protein, no 
abnormality of coagulopathy, and no suspicious sign of vascu-
litis. While continuation of warfarin treatment and medica-
tion in regards of rhematoid arthritis diagnosed in 2007, she 
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was referred to Pediatrics Cardiology for PFO closure. Brain 
magnetic resonance imaging showed signs of stroke and trans-
catheter closure of PFO was scheduled. Contrast echocardiogra-
phy performed via the left upper extremity prior to the proce-
dure showed sequential filling of the bubble in the LA followed 
by left ventricle and then through the PFO to the right atrium 
(Fig. 1). For further evaluation, heart computed tomography 
(CT) was performed and an abnormal connection of LSVC to 
LSPV which drained into LA was diagnosed (Fig. 2).
Under local anesthesia, we first evaluated the patient’s he-
modynamic data to confirm any presence of pulmonary hyper-
tension and patency of coronary artery which showed normal 
findings. Through venous approach via right femoral vein, 7 
French guiding catheter passed right atrium and innominate 
vein approaching to LSVC. The proximal and distal part of 
the LSVC were measured 9.8 and 9.6 mm, respectively by an-
giography (Fig. 3). The abnormal connection between LSVC 
and LSPV was closed using the Amplatzer® Vascular Plug II 
(diameter = 12 mm; St. Jude Medical, St. Paul, MN, USA) 
(Fig. 4). After checked up size of PFO by sizing balloon, trans-
catheter PFO closure with Amplatzer® PFO occluder (diame-
ter = 25 mm; St. Jude Medical, St. Paul, MN, USA) was also 
Fig. 1. Agitation saline injection test. On contrast echo conducted on Rt. arm, the enhancement was seen at not only Rt. side of heart, but also Lt. 
side. Sequential filling of the bubble in the left atrium followed by left ventricle and then through the patent foramen ovale to the right atrium. On Lt. 
arm contrast echocardiography, massive amount of microbubbles draining straight to LA was detected. LA: left atrium, LV: left ventricle, RA: right 
atrium, RV: right ventricle.
Fig. 2. Abnormal Drainage of LSVC to LUPV are shown on three 
dimensional computed tomography. LSVC: left superior vena cava, 
LUPV: left upper pulmonary vein, RSVC: right superior vena cava.
Fig. 3. Angiogram. Abnormal connection of LSVC to left atrium was 
shown on angiogram. LSVC: left superior vena cava, LUPV: left upper 
pulmonary vein.
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performed (Fig. 5). Follow-up echocardiogram showed com-
plete occlusion of flow through the LSVC and PFO.
Discussion
In recent years, transthoracic echocardiogram (TTE) or 
transesophageal echocardiography in patients who have had 
TIA or stroke has become a routine assessment. A contrast 
echocardiography is usually performed by injecting micro-
bubbles through the peripheral intravenous (IV) line, and act-
ed the Valsalva maneuver to determine the presence of right-
to-left shunting across the PFO. In our patient, the IV line 
was first started on the right arm and the contrast echocar-
diography was performed, which proved the presence of PFO. 
On contrast echo conducted on Rt. arm, the enhancement was 
seen at not only Rt. side of heart, but also Lt. side. On careful 
review by an experienced doctor, small amount of direct flow 
into the LA was recognized. Another IV line was started on 
the left arm of the patient. The contrast echo was done as a 
same way on Lt. arm. On repeated contrast echocardiography, 
massive amount of microbubbles draining straight to LA was 
detected. Heart CT was performed to determine the precise 
LSVC drainage, resulting persistent LSVC persistent LSVC 
connection to LSPV was diagnosed.  
 Incidence of persistent LSVC is 0.5% of the general popu-
lation and increased to 4.3% in patients with congenital heart 
disease.6)7) Persistent LSVC draining into the coronary sinus 
and the right atrium is of no hemodynamic significance. But 
persistent LSVC draining directly or through an unroofed cor-
onary sinus into the left atrium represents the same risks as all 
other lesions with right-to-left shunt and forms a substrate for 
paradoxical embolism. If complications related to the right-
to-left shunt occur, correction is indicated.8) In this case of our 
patient, relatively young age at the time of stroke develop-
ment probably indicates that both PFO and persistent LSVC 
was the cause of paradoxical embolism. 
Although our team came across the diagnosis by the keen 
sense of an experienced doctor, in order to increase the chance 
of the detection of persistent LSVC, the authors recommend 
performing contrast echocardiography through the left arm 
peripheral IV line, or through both right and left, if the pa-
tients consent to it. However, the right-to-left shunt through 
this persistent vein is usually not sufficient enough to provoke 
clinically significant systemic desaturation. Therefore, if clini-
cally suspected, a complete evaluation for this anomaly should 
also be considered.
There are many devices used to occlude vessels, the Amp-
latzer® vascular device is easily conformable and has a wide 
range of sizes.9) After device closure, the patient was followed-
Fig. 4. Abnormal drainage of left superior vena cava and left upper pulmonary vein was closed using the Amplatzer® vascular plug II.
Fig. 5. Transcatheter PFO closure with Amplatzer® PFO occluder. PFO: 
patent foramen ovale.
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up regularly thereafter and she is free from additional neuro-
logic attacks, and on follow-up TTE, no residual shunting 
through both device was detected.
In conclusion, we report a successful simultaneous closure of 
PFO using the Amplatzer® PFO occluder (St. Jude Medical, St. 
Paul, MN, USA) and persistent LSVC connection to LSPV us-
ing the Amplatzer® Vascular Plug II (St. Jude Medical, St. 
Paul, MN, USA). In routine work-up performed on TIA or 
stroke patients, in order to increase the chance of diagnosing 
additional right-to-left shunting other than PFO, the authors 
suggest performing contrast echocardiography through the 
left arm peripheral IV line, or on both arm if the patients con-
sent to it.10)
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